News|Videos|May 5, 2026

Weight Loss and Cancer Risk: How Much Weight Loss Needs to Occur?

Jennifer A. Ligibel, MD, discussed the complex link between weight loss and cancer risk, exploring data from bariatric surgery and the emerging role of GLP-1s.

The link between obesity and cancer is well-established, with research connecting excess body weight to an increased risk of 13 different types of cancer, as well as higher rates of recurrence and mortality.1 However, a critical question remains for both patients and clinicians: Exactly how much weight must be lost to change a person's clinical trajectory?

In this interview, Jennifer A. Ligibel, MD, professor at Harvard Medical School and a senior physician in the Breast Oncology Center at the Dana-Farber Cancer Institute, addressed the nuances of this clinical reality. While there isn’t a definitive percentage or pound-count for risk reduction, Ligibel highlighted compelling evidence from bariatric surgery and the burgeoning field of GLP-1 medications. Her insights shed light on why weight is considered a key modifiable factor and what current data suggests about the degree of weight loss necessary to improve long-term outcomes for those at risk of or living with cancer.

Transcript:

We don’t have a clear answer to knowing exactly how much weight somebody needs to lose to either prevent [themselves] from developing cancer or to improve their outcomes once cancer is already developed. There are hundreds of studies that show us that obesity, in particular, is linked to a higher risk of developing 13 different cancers and a higher risk of recurrence and mortality in some of our most common cancers—breast cancer, colon cancer, gynecologic cancers—but we know less about how weight loss could change that trajectory. There are compelling data from the bariatric surgery literature that look at people who underwent bariatric surgery and compare them [with] people who didn’t. These aren’t randomized trials, though, so it’s not something where somebody was assigned to have surgery, but it’s the next best thing, where they took people who had surgery, and they matched them by their age, their weight, their gender, their other medical problems, and then they followed the people over time. It shows that the people who undergo bariatric surgery have a dramatically lower risk of developing cancer, especially the cancers that we think of as being related to obesity.

Now, people lose a lot of weight when they undergo bariatric surgery. It’s not clear that you need to lose that much weight to help reduce your risk of developing cancer, but that’s the data that we have. This is one of the reasons why we’re very excited about the emerging information from GLP-1s: because people lose a lot of weight, but not as much as they did with bariatric surgery, for the most part. There are starting to be some emerging signals that cancer risk may be lower in people who use GLP-1s, although [it is] still very early [in that research]. We don’t know exactly how much weight you need to lose to lower your risk of developing cancer or to hopefully lower the risk of it coming back if it [has been] developed, but we have these emerging data that are coming to us from these different types of weight loss strategies to show that weight does seem to be a modifiable factor.

Reference

Obesity and cancer. CDC. June 11, 2025. Accessed April 30, 2026. https://tinyurl.com/32mjn9wv

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.


Latest CME